374 related articles for article (PubMed ID: 28544627)
21. Expression of selected epithelial-mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers.
Sadlecki P; Jóźwicki J; Antosik P; Grabiec M
Tumour Biol; 2018 Jun; 40(6):1010428318784807. PubMed ID: 29952249
[TBL] [Abstract][Full Text] [Related]
22. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma.
Zhou B; Chen WL; Wang YY; Lin ZY; Zhang DM; Fan S; Li JS
J Oral Pathol Med; 2014 Sep; 43(8):585-92. PubMed ID: 24645915
[TBL] [Abstract][Full Text] [Related]
23. Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.
Liao TT; Yang MH
Mol Oncol; 2017 Jul; 11(7):792-804. PubMed ID: 28649800
[TBL] [Abstract][Full Text] [Related]
24. Cancer-associated-fibroblasts and tumour cells: a diabolic liaison driving cancer progression.
Cirri P; Chiarugi P
Cancer Metastasis Rev; 2012 Jun; 31(1-2):195-208. PubMed ID: 22101652
[TBL] [Abstract][Full Text] [Related]
25. Molecular Pathways Mediating Metastases to the Brain via Epithelial-to-Mesenchymal Transition: Genes, Proteins, and Functional Analysis.
Jeevan DS; Cooper JB; Braun A; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2016 Feb; 36(2):523-32. PubMed ID: 26851006
[TBL] [Abstract][Full Text] [Related]
26. Telomerase reverse transcriptase promotes epithelial-mesenchymal transition and stem cell-like traits in cancer cells.
Liu Z; Li Q; Li K; Chen L; Li W; Hou M; Liu T; Yang J; Lindvall C; Björkholm M; Jia J; Xu D
Oncogene; 2013 Sep; 32(36):4203-13. PubMed ID: 23045275
[TBL] [Abstract][Full Text] [Related]
27. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
28. Epithelial-mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer?
van Staalduinen J; Baker D; Ten Dijke P; van Dam H
Oncogene; 2018 Nov; 37(48):6195-6211. PubMed ID: 30002444
[TBL] [Abstract][Full Text] [Related]
29. Aberrant cancer metabolism in epithelial-mesenchymal transition and cancer metastasis: Mechanisms in cancer progression.
Huang R; Zong X
Crit Rev Oncol Hematol; 2017 Jul; 115():13-22. PubMed ID: 28602165
[TBL] [Abstract][Full Text] [Related]
30. miR-181b-3p promotes epithelial-mesenchymal transition in breast cancer cells through Snail stabilization by directly targeting YWHAG.
Yoo JO; Kwak SY; An HJ; Bae IH; Park MJ; Han YH
Biochim Biophys Acta; 2016 Jul; 1863(7 Pt A):1601-11. PubMed ID: 27102539
[TBL] [Abstract][Full Text] [Related]
31. Cancer-associated fibroblasts are the main contributors to epithelial-to-mesenchymal signatures in the tumor microenvironment.
Szabo PM; Vajdi A; Kumar N; Tolstorukov MY; Chen BJ; Edwards R; Ligon KL; Chasalow SD; Chow KH; Shetty A; Bolisetty M; Holloway JL; Golhar R; Kidd BA; Hull PA; Houser J; Vlach L; Siemers NO; Saha S
Sci Rep; 2023 Feb; 13(1):3051. PubMed ID: 36810872
[TBL] [Abstract][Full Text] [Related]
32. Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.
Suarez-Carmona M; Bourcy M; Lesage J; Leroi N; Syne L; Blacher S; Hubert P; Erpicum C; Foidart JM; Delvenne P; Birembaut P; Noël A; Polette M; Gilles C
J Pathol; 2015 Aug; 236(4):491-504. PubMed ID: 25880038
[TBL] [Abstract][Full Text] [Related]
33. The multiverse nature of epithelial to mesenchymal transition.
Simeone P; Trerotola M; Franck J; Cardon T; Marchisio M; Fournier I; Salzet M; Maffia M; Vergara D
Semin Cancer Biol; 2019 Oct; 58():1-10. PubMed ID: 30453041
[TBL] [Abstract][Full Text] [Related]
34. Cadherins and epithelial-to-mesenchymal transition.
Gheldof A; Berx G
Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-mesenchymal transition in cholangiocarcinoma: From clinical evidence to regulatory networks.
Vaquero J; Guedj N; Clapéron A; Nguyen Ho-Bouldoires TH; Paradis V; Fouassier L
J Hepatol; 2017 Feb; 66(2):424-441. PubMed ID: 27686679
[TBL] [Abstract][Full Text] [Related]
36. Cancer-associated fibroblasts in digestive tumors.
Huang L; Xu AM; Liu S; Liu W; Li TJ
World J Gastroenterol; 2014 Dec; 20(47):17804-18. PubMed ID: 25548479
[TBL] [Abstract][Full Text] [Related]
37. ZEB/miR-200 feedback loop: at the crossroads of signal transduction in cancer.
Hill L; Browne G; Tulchinsky E
Int J Cancer; 2013 Feb; 132(4):745-54. PubMed ID: 22753312
[TBL] [Abstract][Full Text] [Related]
38. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
39. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
40. Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis.
Lu W; Kang Y
Dev Cell; 2019 May; 49(3):361-374. PubMed ID: 31063755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]